SEARCH RESULTS

330026 RESULTS

Research Brief: Medivation Scales Back

COMMUNITY NEWS 2010-04-01 Community News Following disappointing results in its Phase 3 CONNECTION trial of Dimebon for Alzheimer disease (AD), Medivation, Inc., is cutting its workforce. According to the company website, it will reduce staff by 20 percent, end recruitment of a ch

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE